OX40配体在新月体性肾小球肾炎效应期具有抑制作用
本研究在小鼠新月体性肾小球肾炎(GN)效应期阻断OX40L,发现抑制OX40L会加重肾损伤,表现为新月体形成增加、蛋白尿和肾小球白细胞积聚。机制上,抗OX40L治疗增加淋巴结CD4 T细胞增殖、减少Treg增殖与TGFβ产生及foxp3表达,并在肾脏增强CD4和CD8 T细胞的IFNγ表达、促进巨噬细胞向促炎M1表型极化。结论:OX40L在效应期通过抑制CD4 T细胞扩增、增强Treg反应及局部抑制T细胞IFNγ和促炎巨噬细胞表型发挥保护作用。
要点
- 抑制OX40L加重小鼠新月体性GN,表现为新月体、蛋白尿和白细胞积聚增加。
- OX40L阻断增加淋巴结CD4 T细胞增殖并降低Treg增殖与TGFβ产生。
- OX40L中和增强肾脏CD4/CD8 T细胞IFNγ表达并促巨噬细胞M1极化。
核心结论
- OX40L在小鼠新月体性GN效应期具有保护作用,抑制它会加重肾损伤。
研究设计与样本
- 小鼠新月体性GN模型:第0天羊球蛋白/佐剂免疫,第10天注射羊抗小鼠GBM Ig。
- 第10-18天给予大鼠IgG或中和性抗OX40L抗体,第20天评估免疫反应和肾损伤。
主要发现
- 与naïve动物相比,GN小鼠淋巴结和肾脏白细胞及 resident non-immune细胞上OX40L上调。
- 抗OX40L治疗增加新月体形成、蛋白尿和肾小球白细胞积聚。
- 抗OX40L增加淋巴结CD4 T细胞增殖、减少凋亡,不影响淋巴结CD4细胞因子产生和CD8 T细胞反应。
- 阻断OX40L降低淋巴结Treg增殖、TGFβ产生和foxp3表达,不影响B细胞扩增或循环抗体水平。
- 肾脏中中和OX40L增强CD4和CD8 T细胞IFNγ表达,并促使巨噬细胞向促炎M1表型极化。
临床怎么用
- 提示OX40L通路在新月体性GN效应期可能为保护性,靶向抑制需谨慎评估。
局限性
- 研究为小鼠模型,结论外推到人类需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The functional relevance of OX40 ligand (OX40L) in the effector phase of crescentic glomerulonephritis (GN) is unknown. These studies defined the role of endogenous OX40L during the effector stage of murine crescentic GN. METHODS: GN was induced by immunization with sheep globulin/adjuvant on Day 0 and injection of sheep anti-mouse glomerular basement membrane immunoglobulin (Ig) on Day 10. Rat IgG or neutralizing anti-OX40L antibody was administered on Days 10-18 and immune responses and renal injury assessed on Day 20. RESULTS: Compared with naïve animals, OX40L was upregulated in the lymph nodes (LNs) and on leucocytes and resident non-immune cells in the kidneys of mice with GN. Inhibition of OX40L in GN augmented renal injury, as indicated by increased crescent formation, proteinuria and glomerular leucocyte accumulation. In line with increased injury, anti-OX40L treatment increased proliferation and decreased apoptosis of CD4 T cells in the LNs, without affecting LN CD4 cytokine production and CD8 T-cell responses. Blockade of OX40L decreased LN regulatory T-cell (Treg) proliferation, transforming growth factor β production and foxp3 expression. OX40L inhibition did not affect B cell expansion or circulating antibody levels. In the kidney, neutralization of OX40L augmented interferon γ (IFNγ) expression by CD4 and CD8 T cells and shifted macrophage polarization towards the pro-inflammatory M1 phenotype. CONCLUSIONS: OX40L is protective during the effector phase of murine crescentic GN by reducing the expansion of CD4 T cells and enhancing Treg responses in the LNs, and by locally inhibiting T-cell IFNγ production and pro-inflammatory macrophage phenotype in the kidney.
引用
- Odobasic D, Ruth AJ, Oudin V, et al. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis. Nephrol Dial Transplant. 2019. PMID: 29939347. doi:10.1093/ndt/gfy177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。